Epitalon in Australia: legal status and listed suppliers

Legal status in Australia

Not an approved medicine. Not listed by name in the Poisons Standard (June 2026).

As understood at 2026-09-22. Verify with the TGA.

What Epitalon is

Epitalon is a synthetic four-amino-acid peptide (Ala-Glu-Asp-Gly) designed from the amino acid composition of epithalamin, an extract of the bovine pineal gland. It comes from the same Russian bioregulator programme as several other peptides on this site. Twenty-five years of published work is in cells, animals and computer models; there is no human trial among the papers linked here.

Full Epitalon page: targets and research →

Listed suppliers in Australia

5 of the 10 suppliers we list in Australia list Epitalon. Listed, not endorsed: each row is the supplier’s own stated terms.

Au Peptide Labs Australia For laboratory research use only. Not for human consumption. Aussie Peptides Australia Research use only. Statements have not been evaluated by the TGA. We do not ship internationally at this time. Australian Peptide Site Australia Intended for laboratory and scientific research use only. Pept Australia Products sold by Pept are intended for laboratory research purposes only and are not approved for human consumption. Synapse Peptides Australia Australia All products are supplied strictly for research purposes only and are not intended for human or veterinary use.

Clinical Research

Overview of Epitalon - Highly Bioactive Pineal Tetrapeptide with Promising Properties

Araj SK, Brzezik J, Madra-Gackowska K, Szeleszczuk L (2025). International Journal of Molecular Sciences. review n/a (review of 25 years of in vitro, animal and computational work)

Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells

Khavinson VK, Bondarev IE, Butyugov AA (2003). Bulletin of Experimental Biology and Medicine. in-vitro cultured human fetal fibroblasts, a cell type that does not normally express telomerase

Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice

Anisimov VN, Khavinson VK, Provinciali M, et al. (2002). International Journal of Cancer. animal female HER-2/neu transgenic mice, treated monthly from 2 months of age, against saline and a comparison peptide

Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro

Yue X, Liu SL, Guo JN, et al. (2022). Aging. in-vitro mouse oocytes aged in culture for 6, 12 and 24 hours after ovulation